Correlation Between Verastem and Elevation Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Verastem and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verastem and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verastem and Elevation Oncology, you can compare the effects of market volatilities on Verastem and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verastem with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verastem and Elevation Oncology.

Diversification Opportunities for Verastem and Elevation Oncology

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Verastem and Elevation is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Verastem and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Verastem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verastem are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Verastem i.e., Verastem and Elevation Oncology go up and down completely randomly.

Pair Corralation between Verastem and Elevation Oncology

Given the investment horizon of 90 days Verastem is expected to generate 0.83 times more return on investment than Elevation Oncology. However, Verastem is 1.21 times less risky than Elevation Oncology. It trades about 0.04 of its potential returns per unit of risk. Elevation Oncology is currently generating about 0.02 per unit of risk. If you would invest  476.00  in Verastem on November 28, 2024 and sell it today you would earn a total of  66.00  from holding Verastem or generate 13.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Verastem  vs.  Elevation Oncology

 Performance 
       Timeline  
Verastem 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Verastem are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Verastem displayed solid returns over the last few months and may actually be approaching a breakup point.
Elevation Oncology 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Elevation Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable technical and fundamental indicators, Elevation Oncology is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Verastem and Elevation Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Verastem and Elevation Oncology

The main advantage of trading using opposite Verastem and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verastem position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.
The idea behind Verastem and Elevation Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges